Cargando…
Mass Drug Administration for Trachoma: How Long Is Not Long Enough?
BACKGROUND: Blinding trachoma is targeted for elimination by 2020 using the SAFE strategy (Surgery, Antibiotics, Facial cleanliness, and Environmental improvements). Annual mass drug administration (MDA) with azithromycin is a cornerstone of this strategy. If baseline prevalence of clinical signs of...
Autores principales: | Jimenez, Violeta, Gelderblom, Huub C., Mann Flueckiger, Rebecca, Emerson, Paul M., Haddad, Danny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370651/ https://www.ncbi.nlm.nih.gov/pubmed/25799168 http://dx.doi.org/10.1371/journal.pntd.0003610 |
Ejemplares similares
-
Safe mass drug administration and trachoma elimination
por: Addiss, David, et al.
Publicado: (2019) -
Using a case study approach to document ‘preferred practices’ in mass drug administration for trachoma
por: Habtamu, Esmael, et al.
Publicado: (2014) -
The Geographical Distribution and Burden of Trachoma in Africa
por: Smith, Jennifer L., et al.
Publicado: (2013) -
Correction: The Geographical Distribution and Burden of Trachoma in Africa
por: Smith, Jennifer L., et al.
Publicado: (2013) -
An observational assessment of the safety of mass drug administration for trachoma in Ethiopian children
por: Ciciriello, Allan M, et al.
Publicado: (2022)